NCT05314192View on ClinicalTrials.gov

Non-invasive Assessment of Inflammatory Markers MIP-1 Alpha and IL-6 in Saliva of Post Myocardial Infarction and Stage 4 Periodontitis Patients

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

April 15, 2021

Study Completion Date

April 20, 2021

Conditions
Myocardial InfarctionPeriodontal Diseases
Interventions
DIAGNOSTIC_TEST

salivary test

saliva was assessed for MIP-1 alpha

DIAGNOSTIC_TEST

salivary test

saliva was assessed for IL-6

Trial Locations (1)

Unknown

AB shetty Institute of dental sciences, Mangalore

All Listed Sponsors
collaborator

A B Shetty Memorial Institute of Dental Science

OTHER

lead

Ajman University

OTHER

NCT05314192 - Non-invasive Assessment of Inflammatory Markers MIP-1 Alpha and IL-6 in Saliva of Post Myocardial Infarction and Stage 4 Periodontitis Patients | Biotech Hunter | Biotech Hunter